CIK 0001850119 · <br>Emerging growth company
Century Therapeutics, Inc.
Sign in to watch- Ticker
- IPSC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842040295
- Phone
- 215-981-4000
- Business address
- 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
- 4 Open-market sale Chief Operations Officer sold 1,054 shares at $0.78 ($822)
- 4 Open-market sale SVP Finance & Operations sold 351 shares at $0.78 ($274)
- 4 Shares withheld for taxes President and CEO gave up 243,447 shares (to pay taxes)
- 4 Open-market sale Chief Operations Officer sold 1,033 shares at $1.23 ($1,267)
- 4 Open-market sale SVP Finance & Operations sold 283 shares at $1.23 ($347)
- 4 Grant or award Chief Finanical Officer acquired 60,148 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Scientific Officer acquired 74,376 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,000 shares at $1.53 ($7,657)
- 4 Open-market sale Chief Operations Officer sold 1,073 shares at $1.83 ($1,960)
- 4 Open-market sale SVP Finance & Operations sold 289 shares at $1.83 ($528)
- 4 Planned sale See Remarks sold 586 shares at $2.50 ($1,465)
- 4 Planned sale See Remarks sold 1,800 shares at an average $2.52 ($4,529)
- 4 Planned sale See Remarks sold 5,000 shares at $2.84 ($14,179)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 10 · 188 filings